Editorial - Role of Highly Active Antiretroviral Therapy (HAART) for the COVID-19 treatment

Eur Rev Med Pharmacol Sci. 2020 Nov;24(22):11982-11984. doi: 10.26355/eurrev_202011_23861.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antiretroviral Therapy, Highly Active*
  • COVID-19 Drug Treatment*
  • Coronavirus 3C Proteases / antagonists & inhibitors
  • Coronavirus 3C Proteases / metabolism
  • Coronavirus Protease Inhibitors / therapeutic use*
  • Coronavirus RNA-Dependent RNA Polymerase / antagonists & inhibitors
  • Coronavirus RNA-Dependent RNA Polymerase / metabolism
  • Drug Repositioning
  • HIV Infections / drug therapy*
  • Humans
  • Integrase Inhibitors / therapeutic use
  • Reverse Transcriptase Inhibitors / therapeutic use*
  • SARS-CoV-2 / metabolism*
  • Severity of Illness Index
  • Viral Protease Inhibitors / therapeutic use

Substances

  • Coronavirus Protease Inhibitors
  • Integrase Inhibitors
  • Reverse Transcriptase Inhibitors
  • Viral Protease Inhibitors
  • Coronavirus RNA-Dependent RNA Polymerase
  • NSP12 protein, SARS-CoV-2
  • Coronavirus 3C Proteases